Skip to main content
Log in

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Blalock, J. E., & Smith, E. M. (1981). Human leukocyte interferon (HuIFN-a): potent endorphin-like opioid activity.Biochemical and Biophysics Research Communication, 101, 472–78.

    Google Scholar 

  • Hill, N. O., Pardue, A., Khan, A., Aleman, C., Dorn, G., & Hill, J. M. (1981). Phase 1 human leukocyte interferon trials in cancer and leukemia.Journal of Clinical Hematology and Oncology, 11, 23–35.

    Google Scholar 

  • Kurane, I., Innis, B. L., Nimmannitya, S., Nisalak, A., Meager, A., & Ennis, F. A. (1993). High levels of interferon alpha in the sera of children with dengue virus infection.American Journal of Tropical Medicine and Hygiene, 48, 222–229.

    Google Scholar 

  • Singh, V. K., Warren, R. P., Odell, J. D., & Cole, P. (1991). Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children.Clinical Immunology and Immunopathology, 61, 448–455.

    Google Scholar 

  • Skurkovich, S., Skurkovich, B., & Bellanti, J. A. (1987). A unifying model of the immunoregulatory role of the interferon system: can interferon produce disease in humans?Clinical Immunology and Immunopathology, 43, 362–373.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stubbs, G. Letter to the editor. J Autism Dev Disord 25, 71–73 (1995). https://doi.org/10.1007/BF02178169

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02178169

Keywords

Navigation